03/13/2024
3:31 PM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:25 PM | Enzo Biochem (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/27/2024
6:22 PM | Cannon Kara (Reporting)
Enzo Biochem (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
9:23 AM | 1 MAIN CAPITAL MANAGEMENT, LLC (Filed by)
Enzo Biochem (Subject)
| Form SC 13G/A | |
02/13/2024
8:35 AM | Enzo Biochem (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G/A | |
02/02/2024
8:00 PM | Enzo Biochem (Issuer)
Radoff Bradley Louis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:01 PM | Enzo Biochem (Issuer)
TAGLIAFERRI MARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/02/2024
8:02 PM | Enzo Biochem (Issuer)
PULLY STEVEN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
7:33 AM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
3:48 PM | Enzo Biochem (Filer)
| Form DEFR14A | |
10/30/2023
3:50 PM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
4:14 PM | 1 MAIN CAPITAL MANAGEMENT, LLC (Filed by)
Enzo Biochem (Subject)
| Form SC 13G | |
09/05/2023
8:35 PM | Cannon Kara (Reporting)
Enzo Biochem (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:19 PM | Enzo Biochem (Filer)
| Form 8-K/A | |
07/24/2023
3:32 PM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
3:20 PM | Enzo Biochem (Subject)
LABORATORY CORP OF AMERICA HOLDINGS (Filed by)
| Form SC 13D/A | |
07/18/2023
8:42 PM | Enzo Biochem (Filer)
| Form 424B3 | |
07/18/2023
11:15 PM | Enzo Biochem (Filer)
| Form EFFECT | |
07/18/2023
12:19 PM | Enzo Biochem (Filer)
| Form S-3/A | |
07/17/2023
12:38 PM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:30 PM | Enzo Biochem (Filer)
| Form S-3/A | |
07/10/2023
4:20 PM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
4:14 PM | Enzo Biochem (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/21/2023
7:44 PM | Enzo Biochem (Filer)
| Form 424B3 | |
06/21/2023
11:15 PM | Enzo Biochem (Filer)
| Form EFFECT | |
06/16/2023
3:45 PM | Enzo Biochem (Filer)
| Form S-3/A | |
06/14/2023
4:14 PM | Enzo Biochem (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/31/2023
3:18 PM | Eckert Patricia (Reporting)
Enzo Biochem (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:15 PM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
7:01 AM | Enzo Biochem (Filer)
| Form S-3/A | |
05/22/2023
5:32 AM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
4:19 PM | Enzo Biochem (Subject)
Radoff Bradley Louis (Filed by)
| Form SC 13D/A | |
05/08/2023
5:30 AM | Enzo Biochem (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
5:31 AM | Enzo Biochem (Filer)
| Form DEFA14A | |
